Veryan Medical is a pioneering brand that was founded in 2005 as a result of a technology spin-out from Imperial College, London. Their focus is on developing innovative solutions for vascular disease based on the link between vessel geometry, blood flow mechanics, and vascular disease. One of their notable achievements is the patenting of the BioMimics 3D Vascular Stent System, an advanced three-dimensional (3D) stent made of nitinol, a nickel-titanium alloy.

In 2018, Veryan became a part of Otsuka Medical Devices, further expanding their capabilities and reach. With a strong emphasis on research and development, their products have received FDA and CE Mark approval. Veryan Medical's solutions are endorsed by renowned international Key Opinion Leaders (KOLs) and are designed to address the challenges faced by physicians, delivering improved clinical outcomes.

Veryan Medical values entrepreneurial individuals who are passionate about making a difference, and their industry-leading executive team brings over 200 years of collective experience in healthcare. Stay informed about their latest news, press releases, events, and career opportunities on their website